Lacktman Quoted on Proposed Registration Process for Telemedicine Prescriptions

21 November 2019 mHealth Intelligence News
Partner Nate Lacktman was quoted in an mHealth Intelligence article, “DEA Launches Registration Process for Prescriptions by Telemedicine,” about a long-awaited Justice Department proposal to create a special registration process that would allow health care providers to use telemedicine to prescribe controlled substances.

Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team, has long called for such a move, the article pointed out, quoting from a blog post he co-authored in 2018 in which he said that existing regulations “fail to account for how legitimate telemedicine services are delivered today.”